The medical exoskeleton market value is estimated to be US$ 394.3 million in 2024. Global population aging is on the rise, creating a greater need for assistive exoskeleton devices for regular activities or rehabilitation.
The market is predicted to rise at a robust CAGR of 29.1% during the forecast period. The global medical exoskeleton industry's share is estimated to reach a value of nearly US$ 5,100 million by 2034.
Medical Exoskeleton Market Trends & Analysis
| Report Attribute | Details |
|---|---|
| Medical Exoskeleton Market Size (2024) | US$ 394.3 million |
| Market Anticipated Forecast Value (2034) | US$ 5,100 million |
| Market Projected Growth Rate (2024 to 2034) | 29.1% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The net revenue generated from sales of medical exoskeletons globally was US$ 98 million in 2019. In the following years, the sales increased at an astounding rate of 38.4% on average till 2023. The overall market value was US$ 301 million in 2023.
A move toward home-based healthcare solutions or rehabilitating in-home settings surged the sales of exoskeleton suits during this period. This trend is likely to continue ahead and drive the market growth over the next ten years.
| Attributes | Details |
|---|---|
| Medical Exoskeleton Market Value (2019) | US$ 98 million |
| Market Revenue (2023) | US$ 301 million |
| Market Historical Growth Rate (CAGR 2019 to 2023) | 38.4% CAGR |
As per recent global health reports, neurological problems are becoming more common among all age groups, affecting the mobility of limbs and the body. So, the development of exoskeletons by combining different sensors and algorithms for better obstacle recognition, motion tracking, and stability is likely to get popular among patients suffering from diseases like spinal cord injuries and stroke.
Combining augmented reality (AR) and virtual reality (VR), like immersive technologies, is a current trend to improve patients' rehabilitation experience. The integration of more modern aids to make wearable exoskeleton devices more engaging and effective has increased their demand and use in old-age homes or rehabilitation facilities.
Principal Consultant
The table below lists the countries with higher estimated CAGRs as per the medical exoskeleton industry analysis report for 2024 to 2034.
| Regional Market Comparison | CAGR (2024 to 2034) |
|---|---|
| United States | 28.6% |
| Japan | 30.7% |
| United Kingdom | 29.8% |
| South Korea | 31.4% |
| China | 30.2% |
The United States medical exoskeleton market is projected to grow at a rate of 28.6% through the forecasted years. The net worth of this leading market is poised to be around US$ 911.1 million by 2034.
Demand for medical exoskeletons in the United Kingdom is expected to increase at a rate of 29.8% per year till 2034. The United Kingdom market valuation is expected to reach almost US$ 207.2 million by 2034 end.
The medical exoskeleton industry in China is forecasted to advance at a rate of 30.2% over the forecast years. The net worth of the regional market is expected to reach US$ 830.5 million by 2034.
Production and sales of medical exoskeletons in Japan are likely to increase at a promising rate of 30.7% during the forecast years. Net revenue generated by the regional medical exoskeleton manufacturers here is expected to be US$ 593.2 million by 2034.
The medical exoskeleton industries in South Korea are poised to witness the most lucrative growth rate of 31.4% on average between 2024 and 2034. Their combined valuation by 2034 end is forecasted to be around US$ 297.9 million.
Based on product type, powered exoskeleton devices are leading the market. This segment is expected to witness a growth rate of 28.8% over the next ten years.
| Attributes | Details |
|---|---|
| Top Product Type or Segment | Powered Exoskeleton |
| Market Segment Growth Rate from 2024 to 2034 | 28.8% CAGR |
| Market Segment Growth Rate from 2019 to 2023 | 32.1% CAGR |
Based on mobility type, the stationary exoskeleton segment dominates over the mobile exoskeleton segment. The stationary exoskeleton segment is forecasted to further expand at a rate of 28.5% per year through 2034.
| Attributes | Details |
|---|---|
| Top Mobility Type or segment | Stationary Exoskeleton |
| Market Segment Growth Rate from 2024 to 2034 | 28.5% CAGR |
| Market Segment Growth Rate from 2019 to 2023 | 31.8% CAGR |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The overall market is comparatively less competitive as very few companies have been able to establish a successful business with the necessary technology and infrastructure. By providing choices for financing, leading medical exoskeletons are attracting patients struggling financially, thereby motivating medical institutions to use their products more.
Meanwhile, new market players are adopting the strategy of working along with medical facilities and rehabilitation institutes to scale up their businesses fast and increase market presence.
Recent Developments in the Global Medical Exoskeleton Market
| Attribute | Details |
|---|---|
| Estimated Market Size (2024) | US$ 394.3 million |
| Projected Market Size (2034) | US$ 5,100 million |
| Anticipated Growth Rate (2024 to 2034) | 29.1% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | US$ million or billion for Value and Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, Middle East & Africa (MEA), East Asia, South Asia and Oceania |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa |
| Key Segments Covered | By Product Type, By Application, By Mobility, By Component, and By Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global medical exoskeleton market is estimated to be US$ 394.3 million in 2024.
The global medical exoskeleton market is to grow at 29.1% during the forecast period.
The global medical exoskeleton market is to be valued at US$ 5,100 million by 2034.
The global medical exoskeleton market was valued at US$ 98 million in 2019.
China accounts for nearly 16% share of the global medical exoskeleton market.
South Korea to witness a CAGR of 31.4% in sales of medical exoskeletons through 2034.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2024 to 2034
5.3.1. Powered exoskeleton
5.3.2. Passive exoskeleton
5.4. Y-o-Y Growth Trend Analysis By Type, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Type, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Mobility
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Mobility, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Mobility, 2024 to 2034
6.3.1. Stationary
6.3.2. Mobile
6.4. Y-o-Y Growth Trend Analysis By Mobility, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Mobility, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Component
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Component, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Component, 2024 to 2034
7.3.1. Hardware
7.3.2. Software
7.4. Y-o-Y Growth Trend Analysis By Component, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By Component, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034
8.3.1. Spinal Cord Injury
8.3.2. Stroke
8.3.3. Others
8.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023
8.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
9.3.1. North America
9.3.2. Latin America
9.3.3. Western Europe
9.3.4. Eastern Europe
9.3.5. South Asia and Pacific
9.3.6. East Asia
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Type
10.2.3. By Mobility
10.2.4. By Component
10.2.5. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By Mobility
10.3.4. By Component
10.3.5. By Application
10.4. Key Takeaways
11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Type
11.2.3. By Mobility
11.2.4. By Component
11.2.5. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Mobility
11.3.4. By Component
11.3.5. By Application
11.4. Key Takeaways
12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. UK
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Western Europe
12.2.2. By Type
12.2.3. By Mobility
12.2.4. By Component
12.2.5. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Mobility
12.3.4. By Component
12.3.5. By Application
12.4. Key Takeaways
13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. Poland
13.2.1.2. Russia
13.2.1.3. Czech Republic
13.2.1.4. Romania
13.2.1.5. Rest of Eastern Europe
13.2.2. By Type
13.2.3. By Mobility
13.2.4. By Component
13.2.5. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By Mobility
13.3.4. By Component
13.3.5. By Application
13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. India
14.2.1.2. Bangladesh
14.2.1.3. Australia
14.2.1.4. New Zealand
14.2.1.5. Rest of South Asia and Pacific
14.2.2. By Type
14.2.3. By Mobility
14.2.4. By Component
14.2.5. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By Mobility
14.3.4. By Component
14.3.5. By Application
14.4. Key Takeaways
15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. China
15.2.1.2. Japan
15.2.1.3. South Korea
15.2.2. By Type
15.2.3. By Mobility
15.2.4. By Component
15.2.5. By Application
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Type
15.3.3. By Mobility
15.3.4. By Component
15.3.5. By Application
15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Type
16.2.3. By Mobility
16.2.4. By Component
16.2.5. By Application
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Type
16.3.3. By Mobility
16.3.4. By Component
16.3.5. By Application
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2023
17.1.2.1. By Type
17.1.2.2. By Mobility
17.1.2.3. By Component
17.1.2.4. By Application
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2023
17.2.2.1. By Type
17.2.2.2. By Mobility
17.2.2.3. By Component
17.2.2.4. By Application
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2023
17.3.2.1. By Type
17.3.2.2. By Mobility
17.3.2.3. By Component
17.3.2.4. By Application
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2023
17.4.2.1. By Type
17.4.2.2. By Mobility
17.4.2.3. By Component
17.4.2.4. By Application
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2023
17.5.2.1. By Type
17.5.2.2. By Mobility
17.5.2.3. By Component
17.5.2.4. By Application
17.6. UK
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2023
17.6.2.1. By Type
17.6.2.2. By Mobility
17.6.2.3. By Component
17.6.2.4. By Application
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2023
17.7.2.1. By Type
17.7.2.2. By Mobility
17.7.2.3. By Component
17.7.2.4. By Application
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2023
17.8.2.1. By Type
17.8.2.2. By Mobility
17.8.2.3. By Component
17.8.2.4. By Application
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2023
17.9.2.1. By Type
17.9.2.2. By Mobility
17.9.2.3. By Component
17.9.2.4. By Application
17.10. Poland
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2023
17.10.2.1. By Type
17.10.2.2. By Mobility
17.10.2.3. By Component
17.10.2.4. By Application
17.11. Russia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2023
17.11.2.1. By Type
17.11.2.2. By Mobility
17.11.2.3. By Component
17.11.2.4. By Application
17.12. Czech Republic
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2023
17.12.2.1. By Type
17.12.2.2. By Mobility
17.12.2.3. By Component
17.12.2.4. By Application
17.13. Romania
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2023
17.13.2.1. By Type
17.13.2.2. By Mobility
17.13.2.3. By Component
17.13.2.4. By Application
17.14. India
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2023
17.14.2.1. By Type
17.14.2.2. By Mobility
17.14.2.3. By Component
17.14.2.4. By Application
17.15. Bangladesh
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2023
17.15.2.1. By Type
17.15.2.2. By Mobility
17.15.2.3. By Component
17.15.2.4. By Application
17.16. Australia
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2023
17.16.2.1. By Type
17.16.2.2. By Mobility
17.16.2.3. By Component
17.16.2.4. By Application
17.17. New Zealand
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2023
17.17.2.1. By Type
17.17.2.2. By Mobility
17.17.2.3. By Component
17.17.2.4. By Application
17.18. China
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2023
17.18.2.1. By Type
17.18.2.2. By Mobility
17.18.2.3. By Component
17.18.2.4. By Application
17.19. Japan
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2023
17.19.2.1. By Type
17.19.2.2. By Mobility
17.19.2.3. By Component
17.19.2.4. By Application
17.20. South Korea
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2023
17.20.2.1. By Type
17.20.2.2. By Mobility
17.20.2.3. By Component
17.20.2.4. By Application
17.21. GCC Countries
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2023
17.21.2.1. By Type
17.21.2.2. By Mobility
17.21.2.3. By Component
17.21.2.4. By Application
17.22. South Africa
17.22.1. Pricing Analysis
17.22.2. Market Share Analysis, 2023
17.22.2.1. By Type
17.22.2.2. By Mobility
17.22.2.3. By Component
17.22.2.4. By Application
17.23. Israel
17.23.1. Pricing Analysis
17.23.2. Market Share Analysis, 2023
17.23.2.1. By Type
17.23.2.2. By Mobility
17.23.2.3. By Component
17.23.2.4. By Application
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Type
18.3.3. By Mobility
18.3.4. By Component
18.3.5. By Application
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. CYBERDYNE INC.
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Wearable Robotics srl
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. B-Temia
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. Rewalk Robotics
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. DIH Medical
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Ekso Bionics
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Human Motion Technologies LLC
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. Ottobock SE & Co. KGaA (suit X)
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. ExoAtlet
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. Ergosante
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Medical Exoskeleton Market
